A Single-Center Experience With Preoperative Selective Internal Radiation Therapy (SIRT) With Y-90, as a Bridging Procedure, in Liver Transplant Recipients (OLT) With Unresectable Hepatocellular Carcinoma (uHCC): Benefits and Limitations.

被引:0
|
作者
Fasola, C. [1 ]
Mantry, P. [1 ]
Madani, B. [1 ]
Weinstein, J. [1 ]
Mubarak, A. [1 ]
Nazario, H. [1 ]
Habid, A. [1 ]
Barnes, M. [1 ]
Mejia, A. [1 ]
Dickerman, R. [1 ]
Cheng, S. [1 ]
机构
[1] Methodist Dallas Med Ctr, Liver Inst, Dallas, TX USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
A386
引用
收藏
页码:697 / 697
页数:1
相关论文
共 18 条
  • [11] 90Yttrium Selective Internal Radiation Therapy in Unresectable or Otherwise High-Risk Hepatocellular Carcinoma: Single-Centre Experience
    Leung, K. H.
    Lim, M. Y.
    HONG KONG JOURNAL OF RADIOLOGY, 2023, 26 (01): : 24 - 33
  • [12] Cost effectiveness of selective internal radiation therapy (SIRT) with Y-90 resin microspheres versus sorafenib in Barcelona Clinic Liver Cancer (BCLC) stage C hepatocellular carcinoma patients in the UK
    Palmer, D.
    Ross, P.
    Shah, T.
    Yu, D.
    Shergill, S.
    Patterson, K.
    Brereton, N.
    Lee, D.
    ANNALS OF ONCOLOGY, 2017, 28
  • [13] Use of selective internal radiation therapy with yttrium-90 as a bridge to liver resection: a 5-year single-center experience
    Kalra, Aryan
    Rowcroft, Alistair
    Trinder, Matthew
    Ballal, Mohammed
    Bhandari, Mayank
    JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 28 (12) : 1970 - 1975
  • [14] Safety and Ef fi cacy of 90 Y Selective Internal Radiation Therapy Using Glass Microspheres in Hepatocellular Carcinoma: A Southeast Asian Single-Institution Initial Experience
    Ng, Cherie Wei Qi
    Hassan, Muhammad Jai bin
    Goh, Charles
    Tong, Aaron Kian Ti
    Tham, Wei Ying
    Thang, Sue Ping
    Lam, Winnie Wing-Chuen
    Low, Han Chung
    Magsombol, Butch M.
    Loke, Kelvin Siu Hoong
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2024, 52 (02) : 148 - 151
  • [15] SELECTIVE INTERNAL RADIATION THERAPY USING Y-90 RESIN MICROSPHERES VS CONVENTIONAL TRANSARTERIAL CHEMOEMBOLIZATION IN BARCELONA CLINIC LIVER CANCER STAGE B HEPATOCELLULAR CARCINOMA: A BUDGET IMPACT ANALYSIS IN ENGLAND
    Pollock, R. F.
    Agirrezabal, I.
    Carion, P. L.
    Roe, R.
    Shergill, S.
    Ross, P. J.
    VALUE IN HEALTH, 2022, 25 (12) : S123 - S123
  • [16] T/N ratio and radiation dose delivered do not correlate with the development of Radioembolization-Induced Liver Disease (REILD) in Hepatocellular Carcinoma (HCC) following Y90 selective internal radiation therapy (Y90-SIRT): A retrospective, single tertiary centre cohort study
    Peh, D. Y. Y.
    Chen, K.
    Ong, T. S. K.
    Yeo, E. X.
    Moe, F. N. N.
    Ng, D. C. E.
    Loke, K.
    Yan, S. X.
    Thang, S. P.
    Tong, A.
    Huang, H. L. H.
    Magsombol, B. M.
    Lo, R. H. G.
    Gogna, A.
    Venkatanarasimha, N. K. K.
    Too, C. W.
    Chandramohan, S.
    Zhuang, K. D.
    Chow, P.
    ANNALS OF ONCOLOGY, 2023, 34 : S1536 - S1536
  • [17] A BUDGET IMPACT ANALYSIS OF SELECTIVE INTERNAL RADIATION THERAPY USING Y-90 RESIN MICROSPHERES VERSUS ATEZOLIZUMAB-BEVACIZUMAB AS FIRST-LINE THERAPY IN BARCELONA CLINIC LIVER CANCER STAGE C HEPATOCELLULAR CARCINOMA IN ENGLAND
    Pollock, R. F.
    Agirrezabal, I
    Carion, P. L.
    Roe, R.
    Shergill, S.
    Ross, P. J.
    VALUE IN HEALTH, 2022, 25 (12) : S90 - S90
  • [18] UTILITY VALUES FOR ADVANCED HEPATOCELLULAR CARCINOMA PATIENTS IN FRANCE RECEIVING SELECTIVE INTERNAL RADIATION THERAPY (SIRT) WITH Y-90 RESIN MICROSPHERES VERSUS SORAFENIB USING EQ-5D SCORES MAPPED FROM EORTC-QLQ-C30 RESULTS
    Patterson, K.
    Hart, R.
    Shergill, S.
    Colaone, F.
    Brennan, V
    Durand-Zaleski, I
    Vilgrain, V.
    Lee, D.
    VALUE IN HEALTH, 2018, 21 : S74 - S74